Definitive Contract 75F40121C00167
Award Date
9/13/21
Potential Completion Date
9/16/25
Potential Value
$8.9M
Federal Agency
Food and Drug Administration
Awardee
Embleema Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $350,000 definitive cost-no-fee contract to Elligo Health Research, Inc. to support the agency's Broad Agency Announcement seeking proposals to extend the value of common data model harmonization in generating clinical evidence from real world data sufficient to support regulatory use. The small disadvantaged business will perform work at locations in Silver Spring, Maryland under the contract addressing the FDA's...
<p>This is a $9,671,431.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Safe Health Systems, Inc., a self-certified small disadvantaged business. The contract is for stimulating innovation in clinical evaluations and personalized medicine to improve product development and patient outcome. The contract has no set-aside designation and has an ultimate completion date of March 27, 2026.</p>
This federal contract award, valued at $811,126.00, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract was awarded under a Broad Agency Announcement (BAA) solicitation for research and development to support the FDA's regulatory science and innovation mission. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and has an ultimate completion date of December 31,...
The U.S. Food and Drug Administration (FDA) awarded a $19,731,473.00 definitive contract to Zata Pharmaceuticals, Inc. for the development and maintenance of FDA-ARGOS 2 universal closed systems for pathogen reduction in donated whole blood units. This contract, awarded on September 27, 2021, has a completion date of September 26, 2025 and does not have a set-aside designation. The contract was issued under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which solicits...
The Department of Health and Human Services' Food and Drug Administration awarded a $157,134 firm fixed price delivery order contract to Regan Technologies Corporation. This order is placed against Solutions for Enterprise-Wide Procurement V, a government-wide acquisition contract vehicle, to provide CLC BIO software licenses. The place of performance is Silver Spring, Maryland. The one-year contract begins on September 27, 2023 and concludes on September 29, 2024. As the FDA works to protect...
<p>This federal contract award, valued at $99,300.00, was issued by the Food and Drug Administration (FDA) to Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GMBH, a vendor located in Braunschweig, Germany. The contract is for the provision of 290 genomic nucleic acids for the FDA's ARGOS program, which is focused on genomics. The contract has a firm fixed price and a completion date of September 4, 2019. It is not associated with a set-aside designation.</p>
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Affymetrix, Inc., a for-profit manufacturer, on June 24, 2013. The $20,855 contract is for "OTHER FUNCTIONS 'OTHER' SERVICE FOR GCS3000 ASSURANCE SYSTEM" under the "SERVICE FOR AFFYMETRIX SYSTEM" major program code. The work is to be performed in Bethesda, MD and has a completion date of July 31, 2014. This contract award does not have a set-aside...
This is a $2,469,135.04 definitive, firm-fixed-price contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, an 8(a) certified Small Disadvantaged Business. The contract is for facilitation and coordination support services for IT initiatives, including regulatory review and production support for the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS), support for the Center for Drug Evaluation and Research (CDER),...
This is a $3,629,755.00 Firm Fixed Price definitive contract awarded by the Food and Drug Administration (FDA) to Accenture Federal Services LLC, doing business as Accenture National Security Services. The contract is for the development of a cloud-based transnational regulatory platform to support multi-region regulatory collaboration. This contract was awarded under a Broad Agency Announcement solicitation that sought advanced research and development proposals to modernize FDA's regulatory...
The U.S. Food and Drug Administration (FDA) awarded a $384,225.00 firm fixed price definitive contract to Cycle Computing LLC, a for-profit limited liability company, for a project titled "Elastic Technical Computing for Analyzing Whole-Genome Sequencing Data from Food-Borne Bacterial." The contract has an ultimate completion date of January 10, 2018 and was awarded on April 29, 2015. This contract is not associated with a larger vehicle and does not have a set-aside designation.